Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13.27	23.77	21.1	30.34	13.65
Cash & Cash Equivalents	13.27	23.77	21.1	30.34	13.65
Cash Growth	-44.19%	12.67%	-30.46%	122.30%	-40.08%
Receivables	8.81	1.55	0	0	0
Inventory	2.16	0.58	0	0	0
Other Current Assets	2.62	0.83	1.29	1.07	0.23
Total Current Assets	26.86	26.73	22.39	31.42	13.88
Other Long-Term Assets	0.01	0.21	0.03	0	0.26
Total Long-Term Assets	0.01	0.21	0.03	0	0.26
Total Assets	26.86	26.94	22.41	31.42	14.15
Accounts Payable	3.78	2.39	0.78	1.57	1.61
Current Debt	0.02	0	0	0	0
Other Current Liabilities	3.75	2.22	0.88	0.78	0.66
Total Current Liabilities	7.55	4.61	1.65	2.35	2.27
Long-Term Debt	29.71	24.64	4.99	0	0
Other Long-Term Liabilities	1.22	0.26	0	0	0
Total Long-Term Liabilities	30.93	24.9	4.99	0	0
Total Liabilities	38.49	29.51	6.64	2.35	2.27
Total Debt	29.74	24.64	4.99	0	0
Debt Growth	20.68%	393.97%	-	-	-
Retained Earnings	-219.25	-203.2	-179.49	-162.14	-144.03
Comprehensive Income	1.24	1.24	1.24	1.24	1.24
Shareholders' Equity	-11.62	-2.57	15.77	29.07	11.88
Net Cash / Debt	-16.47	-0.87	16.11	30.34	13.65
Net Cash / Debt Growth	-	-	-46.90%	122.30%	-40.08%
Net Cash Per Share	-0.62	-0.03	0.62	1.28	0.69
Working Capital	19.31	22.12	20.73	29.07	11.61
Book Value Per Share	-0.44	-0.10	0.61	1.23	0.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).